Central abdominal uptake of indium-111 capromab pendetide (ProstaScint) predicts for poor prognosis in patients with prostate cancer (Q46467822)

22 December 2017

title

Central abdominal uptake of indium-111 capromab pendetide (ProstaScint) predicts for poor prognosis in patients with prostate cancer (English)

1 reference

22 December 2017

author name string

Michael K Haseman

1

1 reference

22 December 2017

Seth A Rosenthal

2

1 reference

22 December 2017

Samuel L Kipper

3

1 reference

22 December 2017

J Richard Trout

4

1 reference

22 December 2017

Michael J Manyak

5

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

22 December 2017

published in

Urology

1 reference

22 December 2017

volume

70

1 reference

22 December 2017

issue

2

1 reference

22 December 2017

page(s)

303-308

1 reference

22 December 2017

cites work

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.03.069

Probability of biochemical recurrence by analysis of pathologic stage, Gleason score, and margin status for localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.03.069

Counseling Men With Prostate Cancer: A Nomogram for Predicting the Presence of Small, Moderately Differentiated, Confined Tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.03.069

Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.03.069

Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.03.069

Western blot assay for prostate-specific membrane antigen in serum of prostate cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.03.069

Location of prostate-specific membrane antigen in the LNCaP prostate carcinoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.03.069

Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.03.069

Multicenter radioimmunoscintigraphic evaluation of patients with prostate carcinoma using indium-111 capromab pendetide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.03.069

Monoclonal antibody imaging of occult prostate cancer in patients with elevated prostate-specific antigen. Positron emission tomography and biopsy correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.03.069

Update on fused capromab pendetide imaging of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.03.069

ProstaScint (capromab pendetide) imaging using hybrid gamma camera-CT technology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.03.069

Capromab Pendetide imaging of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.03.069

Radioimmunoguided imaging of prostate cancer foci with histopathological correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.03.069

Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.03.069

Lymph node staging of localized prostatic carcinoma with CT and CT-guided fine-needle aspiration biopsy: prospective study of 285 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.03.069

Lymphangiography combined with biopsy and computer tomography to detect lymph node metastases in localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.03.069

Pelvic adenopathy from bladder and prostate carcinoma: detection by rapid-sequence computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.03.069

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.03.069

Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.03.069

111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. The ProstaScint Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.03.069

Radioimmunoscintigraphy with In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.03.069

Indium-111-capromab pendetide radioimmunoscintigraphy and prognosis for durable biochemical response to salvage radiation therapy in men after failed prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.03.069

The role of 111indium-capromab pendetide imaging for assessing biochemical failure after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.03.069

10.1016/J.UROLOGY.2007.03.069

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017